Suppr超能文献

频域光学相干断层扫描系统之间的横向和轴向测量差异。

Lateral and axial measurement differences between spectral-domain optical coherence tomography systems.

作者信息

Folgar Francisco A, Yuan Eric L, Farsiu Sina, Toth Cynthia A

机构信息

Duke University, Department of Ophthalmology, Durham, North Carolina 27710.

Duke University, Department of Ophthalmology, Durham, North Carolina 27710 bDuke University, Department of Biomedical Engineering, Durham, North Carolina 27710.

出版信息

J Biomed Opt. 2014 Jan;19(1):16014. doi: 10.1117/1.JBO.19.1.016014.

Abstract

We assessed the reproducibility of lateral and axial measurements performed with spectral-domain optical coherence tomography (SDOCT) instruments from a single manufacturer and across several manufacturers. One human retina phantom was imaged on two instruments each from four SDOCT platforms: Zeiss Cirrus, Heidelberg Spectralis, Bioptigen SDOIS, and hand-held Bioptigen Envisu. Built-in software calipers were used to perform manual measurements of a fixed lateral width (LW), central foveal thickness (CFT), and parafoveal thickness (PFT) 1 mm from foveal center. Inter- and intraplatform reproducibilities were assessed with analysis of variance and Tukey-Kramer tests. The range of measurements between platforms was 5171 to 5290 μm for mean LW (p<0.001), 162 to 196 μm for mean CFT (p<0.001), and 267 to 316 μm for mean PFT (p<0.001). All SDOCT platforms had significant differences between each other for all measurements, except LW between Bioptigen SDOIS and Envisu (p=0.27). Intraplatform differences were significantly smaller than interplatform differences for LW (p=0.020), CFT (p=0.045), and PFT (p=0.004). Conversion factors were generated for lateral and axial scaling between SDOCT platforms. Lateral and axial manual measurements have greater variance across different SDOCT platforms than between instruments from the same platform. Conversion factors for measurements from different platforms can produce normalized values for patient care and clinical studies.

摘要

我们评估了使用来自单一制造商以及多个制造商的光谱域光学相干断层扫描(SDOCT)仪器进行横向和轴向测量的可重复性。使用四个SDOCT平台(蔡司Cirrus、海德堡Spectralis、Bioptigen SDOIS和手持式Bioptigen Envisu)中的两台仪器对一个人视网膜模型进行成像。使用内置软件卡尺手动测量固定的横向宽度(LW)、中央凹厚度(CFT)以及距中央凹中心1 mm处的旁中央凹厚度(PFT)。通过方差分析和Tukey-Kramer检验评估平台间和平台内的可重复性。各平台间测量范围如下:平均LW为5171至5290μm(p<0.001),平均CFT为162至196μm(p<0.001),平均PFT为267至316μm(p<0.001)。除Bioptigen SDOIS和Envisu之间的LW(p=0.27)外,所有SDOCT平台在所有测量值之间均存在显著差异。对于LW(p=0.020)、CFT(p=0.045)和PFT(p=0.004),平台内差异显著小于平台间差异。生成了SDOCT平台之间横向和轴向缩放的转换因子。与同一平台的仪器之间相比,不同SDOCT平台的横向和轴向手动测量具有更大的差异。不同平台测量的转换因子可为患者护理和临床研究生成标准化值。

相似文献

2
Understanding the variability of handheld spectral-domain optical coherence tomography measurements in supine infants.
PLoS One. 2019 Dec 11;14(12):e0225960. doi: 10.1371/journal.pone.0225960. eCollection 2019.
3
Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems.
Ophthalmology. 2012 Jan;119(1):119-23. doi: 10.1016/j.ophtha.2011.07.002. Epub 2011 Sep 23.
4
Repeatability of Foveal Measurements Using Spectralis Optical Coherence Tomography Segmentation Software.
PLoS One. 2015 Jun 15;10(6):e0129005. doi: 10.1371/journal.pone.0129005. eCollection 2015.
7
Do different spectral domain OCT hardwares measure the same? Comparison of retinal thickness using third-party software.
Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1915-21. doi: 10.1007/s00417-015-3075-2. Epub 2015 Jun 12.
9
Reproducibility of choroidal thickness measurements in subjects on 3 spectral domain optical coherence tomography machines.
Int Ophthalmol. 2017 Jun;37(3):655-671. doi: 10.1007/s10792-016-0306-4. Epub 2016 Aug 24.
10
Refractive error and ocular parameters: comparison of two SD-OCT systems.
Optom Vis Sci. 2015 Apr;92(4):437-46. doi: 10.1097/OPX.0000000000000559.

引用本文的文献

3
Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity.
Am J Ophthalmol. 2022 Dec;244:98-116. doi: 10.1016/j.ajo.2022.08.013. Epub 2022 Aug 22.
4
Changes of Peripapillary Retinal Nerve Fiber Layer in Childhood Glaucoma: A Systematic Review and Meta-Analysis.
Front Med (Lausanne). 2021 Oct 11;8:740152. doi: 10.3389/fmed.2021.740152. eCollection 2021.
5
Challenges Associated With Ellipsoid Zone Intensity Measurements Using Optical Coherence Tomography.
Transl Vis Sci Technol. 2021 Oct 4;10(12):27. doi: 10.1167/tvst.10.12.27.
6
An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy.
Eye (Lond). 2021 Sep;35(9):2438-2448. doi: 10.1038/s41433-021-01594-y. Epub 2021 Jul 16.
7
8
Subclinical Retinal versus Brain Findings in Infants with Hypoxic Ischemic Encephalopathy.
Graefes Arch Clin Exp Ophthalmol. 2020 Sep;258(9):2039-2049. doi: 10.1007/s00417-020-04738-0. Epub 2020 May 29.
9
Correlation of spectral domain optical coherence tomography with histology and electron microscopy in the porcine retina.
Exp Eye Res. 2018 Dec;177:181-190. doi: 10.1016/j.exer.2018.08.003. Epub 2018 Aug 16.
10
Macular Features on Spectral-Domain Optical Coherence Tomography Imaging Associated With Visual Acuity in Coats' Disease.
Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3161-3174. doi: 10.1167/iovs.18-24109.

本文引用的文献

1
Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography.
Ophthalmology. 2014 Jan;121(1):162-172. doi: 10.1016/j.ophtha.2013.07.013. Epub 2013 Aug 29.
2
Fast acquisition and reconstruction of optical coherence tomography images via sparse representation.
IEEE Trans Med Imaging. 2013 Nov;32(11):2034-49. doi: 10.1109/TMI.2013.2271904. Epub 2013 Jul 3.
3
Evaluation of normal human foveal development using optical coherence tomography and histologic examination.
Arch Ophthalmol. 2012 Oct;130(10):1291-300. doi: 10.1001/archophthalmol.2012.2270.
4
Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.
Ophthalmology. 2013 Jan;120(1):140-50. doi: 10.1016/j.ophtha.2012.07.004. Epub 2012 Sep 8.
5
Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology.
Am J Ophthalmol. 2012 Nov;154(5):779-789.e2. doi: 10.1016/j.ajo.2012.05.004. Epub 2012 Aug 13.
7
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
Ophthalmology. 2012 Jul;119(7):1399-411. doi: 10.1016/j.ophtha.2012.04.015. Epub 2012 May 11.
8
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Ophthalmology. 2012 Jul;119(7):1388-98. doi: 10.1016/j.ophtha.2012.03.053. Epub 2012 May 1.
10
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Ophthalmology. 2012 Apr;119(4):789-801. doi: 10.1016/j.ophtha.2011.12.039. Epub 2012 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验